Loading...
PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer
The incidence of breast cancer brain metastases has increased in recent years, largely due to improved control of systemic disease with human epidermal growth factor receptor 2 (HER2)-targeted agents and the inability of most of these agents to efficiently cross the blood–blood barrier (BBB) and con...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3980725/ https://ncbi.nlm.nih.gov/pubmed/24469856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-014-1369-6 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|